New approach aims to shorten hospital stays for bone cancer patients
NCT ID NCT03960177
Summary
This small, early-stage study is testing whether a drug called glucarpidase can help adults with osteosarcoma (a type of bone cancer) better tolerate their chemotherapy. The goal is to see if giving glucarpidase after high-dose methotrexate treatment reduces side effects and leads to shorter hospital stays. Researchers will monitor 12 participants to see if they can complete all planned chemotherapy doses with fewer complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
-
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.